Guided Therapeutics (GTHP) Non-Current Debt (2013 - 2025)
Guided Therapeutics recorded quarterly Non-Current Debt of $23000.0 in Q4 2025, down 20.69% quarter-over-quarter from $29000.0 in Q3 2025, and down 51.06% year-over-year from $47000.0 in Q4 2024.
Guided Therapeutics' Non-Current Debt history runs 12 years deep, the most recent figure standing at $23000.0 for Q4 2025.
- In Q4 2025, Non-Current Debt fell 51.06% year-over-year to $23000.0; the TTM figure through Dec 2025 stood at $23000.0 (down 51.06% YoY), while the FY2025 annual figure was $23000.0, down 51.06% from the prior year.
- Non-Current Debt came in at $23000.0 for Q4 2025 at Guided Therapeutics, down from $29000.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $586000.0 in Q3 2021 to a low of $6000.0 in Q1 2021.
- A 4-year average of $159500.0 and a median of $50000.0 in 2024 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt plunged 98.96% in 2021 and jumped 9366.67% in 2022, its largest moves.
- Guided Therapeutics' Non-Current Debt stood at $22000.0 in 2021, then surged by 277.27% to $83000.0 in 2022, then plunged by 43.37% to $47000.0 in 2024, then sank by 51.06% to $23000.0 in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $23000.0, $29000.0, and $35000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 27.88 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.81 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23,000.00 |
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Dec 31, 2024 | 47,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Jun 30, 2022 | 102,000.00 |
| Mar 31, 2022 | 568,000.00 |
| Mar 31, 2022 | 568,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 586,000.00 |
| Sep 30, 2021 | 586,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Jun 30, 2021 | 579,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Sep 30, 2020 | 592,000.00 |
| Jun 30, 2020 | 50,000.00 |
| Jun 30, 2020 | 50,000.00 |
| Mar 31, 2020 | 577,000.00 |
| Mar 31, 2020 | 577,000.00 |
| Dec 31, 2019 | 569,000.00 |
| Dec 31, 2019 | 569,000.00 |
| Sep 30, 2019 | 561,000.00 |
| Sep 30, 2019 | 561,000.00 |
| Jun 30, 2019 | 552,000.00 |
| Jun 30, 2019 | 552,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Mar 31, 2019 | 308,000.00 |
| Dec 31, 2018 | 340,000.00 |
| Dec 31, 2018 | 340,000.00 |
| Sep 30, 2018 | 606,000.00 |
| Sep 30, 2018 | 606,000.00 |
| Mar 31, 2017 | 651,000.00 |
| Mar 31, 2017 | 651,000.00 |
| Dec 31, 2016 | 651,000.00 |
| Dec 31, 2016 | 651,000.00 |
| Sep 30, 2016 | 459,000.00 |
| Sep 30, 2016 | 459,000.00 |
| Dec 31, 2015 | 682,000.00 |
| Dec 31, 2015 | 682,000.00 |
| Jun 30, 2015 | 1.03 Mn |
| Jun 30, 2015 | 1.03 Mn |
| Dec 31, 2014 | 40,000.00 |
| Dec 31, 2014 | 40,000.00 |
| Sep 30, 2014 | 40,000.00 |
| Sep 30, 2014 | 40,000.00 |
| Jun 30, 2014 | 4,000.00 |
| Jun 30, 2014 | 4,000.00 |
| Mar 31, 2014 | 99,000.00 |
| Mar 31, 2014 | 99,000.00 |
| Dec 31, 2013 | 103,000.00 |
| Dec 31, 2013 | 103,000.00 |
| Sep 30, 2013 | 135,000.00 |
| Sep 30, 2013 | 135,000.00 |
| Jun 30, 2013 | 157,000.00 |
| Jun 30, 2013 | 157,000.00 |